The appearance of anti-14-3-3 zeta autoantibody in the LC stage in patients with HCC indicates that anti-14-3-3 zeta autoantibody might be predictive of hepatocarcinogenesis in premalignant liver disease. This evidence concerns the gene YWHAQ and hepatocellular carcinoma.